Abdulrahman M, Mansy M, Al-Ghreib K, Johar D, Zaky S
Sci Rep. 2024; 14(1):22273.
PMID: 39333134
PMC: 11436738.
DOI: 10.1038/s41598-024-72289-z.
Voidarou C, Rozos G, Alexopoulos A, Plessas S, Mantzourani I, Stavropoulou E
Foods. 2021; 10(7).
PMID: 34359441
PMC: 8307090.
DOI: 10.3390/foods10071568.
Smith S, Fowora M, Pellicano R
World J Gastroenterol. 2019; 25(25):3183-3195.
PMID: 31333310
PMC: 6626727.
DOI: 10.3748/wjg.v25.i25.3183.
Jaka H, Rhee J, Ostlundh L, Smart L, Peck R, Mueller A
BMC Infect Dis. 2018; 18(1):193.
PMID: 29699490
PMC: 5921563.
DOI: 10.1186/s12879-018-3099-4.
El-Shabrawi M, El-Aziz N, El-Adly T, Hassanin F, Eskander A, Abou-Zekri M
Arch Med Sci. 2018; 14(1):69-73.
PMID: 29379534
PMC: 5778417.
DOI: 10.5114/aoms.2016.61031.
GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS.
Ramzy I, Elgarem H, Hamza I, Ghaith D, Elbaz T, Elhosary W
Rev Inst Med Trop Sao Paulo. 2016; 58:88.
PMID: 27982354
PMC: 5147718.
DOI: 10.1590/S1678-9946201658088.
Primary Antibiotic Resistance to Helicobacter pylori Strains Isolated From Children in Northern Iran: A Single Center Study.
Maleknejad S, Mojtahedi A, Safaei-Asl A, Taghavi Z, Kazemnejad E
Iran J Pediatr. 2015; 25(6):e2661.
PMID: 26635938
PMC: 4662838.
DOI: 10.5812/ijp.2661.
Detection of Helicobacter pylori DNA in Some Egyptian Water Systems and Its Incidence of Transmission to Individuals.
El-Sharouny E, El-Shazli H, Olama Z
Iran J Public Health. 2015; 44(2):203-10.
PMID: 25905054
PMC: 4401878.
Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion.
Ogata S, Gales A, Kawakami E
Braz J Microbiol. 2015; 45(4):1439-48.
PMID: 25763052
PMC: 4323321.
DOI: 10.1590/s1517-83822014000400039.
CagA status & genetic characterization of metronidazole resistant strains of H. pylori from: A region at high risk of gastric cancer.
Yue J, Yue J, Wang M, Song W, Gao X
Pak J Med Sci. 2014; 30(4):804-8.
PMID: 25097521
PMC: 4121702.
DOI: 10.12669/pjms.304.4840.
Treatment of Helicobacter pylori infection: current status and future concepts.
Yang J, Lu C, Lin C
World J Gastroenterol. 2014; 20(18):5283-93.
PMID: 24833858
PMC: 4017043.
DOI: 10.3748/wjg.v20.i18.5283.
Preliminary examination of herbal extracts on the inhibition of Helicobacter pylori.
Guzeldag G, Kadioglu L, Mercimek A, Matyar F
Afr J Tradit Complement Altern Med. 2014; 11(1):93-6.
PMID: 24653559
PMC: 3957247.
Anti-Helicobacter pylori activity and Structure-Activity Relationship study of 2-Alkylthio-5-(nitroaryl)-1,3,4-thiadiazole Derivatives.
Asadipour A, Edraki N, Nakhjiri M, Yahya-Meymandi A, Alipour E, Saniee P
Iran J Pharm Res. 2013; 12(3):281-7.
PMID: 24250634
PMC: 3813270.
Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.
Seck A, Burucoa C, Dia D, Mbengue M, Onambele M, Raymond J
Ann Clin Microbiol Antimicrob. 2013; 12:3.
PMID: 23298145
PMC: 3552979.
DOI: 10.1186/1476-0711-12-3.
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa.
Secka O, Berg D, Antonio M, Corrah T, Tapgun M, Walton R
Antimicrob Agents Chemother. 2012; 57(3):1231-7.
PMID: 23263004
PMC: 3591906.
DOI: 10.1128/AAC.00517-12.
Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran.
Shokrzadeh L, Jafari F, Dabiri H, Baghaei K, Zojaji H, Alizadeh A
Saudi J Gastroenterol. 2011; 17(4):261-4.
PMID: 21727733
PMC: 3133984.
DOI: 10.4103/1319-3767.82581.
In-vitro antimicrobial activity of selected honeys on clinical isolates of Helicobacter pylori.
Ndip R, Malange Takang A, Echakachi C, Malongue A, Akoachere J, Ndip L
Afr Health Sci. 2011; 7(4):228-32.
PMID: 21499488
PMC: 3074369.
Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran.
Talebi Bezmin Abadi A, Ghasemzadeh A, Taghvaei T, Mohabbati Mobarez A
Intern Emerg Med. 2011; 7(5):447-52.
PMID: 21437583
DOI: 10.1007/s11739-011-0563-1.
Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.
Farshad S, Alborzi A, Japoni A, Ranjbar R, Hosseini Asl K, Badiee P
World J Gastroenterol. 2010; 16(45):5746-51.
PMID: 21128326
PMC: 2997992.
DOI: 10.3748/wjg.v16.i45.5746.
Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.
Nishizawa T, Suzuki H, Hibi T
J Clin Biochem Nutr. 2009; 44(2):119-24.
PMID: 19308265
PMC: 2654467.
DOI: 10.3164/jcbn.08-220R.